Zinc and depression. An update
Nowak G, Szewczyk B, Pilc A.
Department of Cytobiology and Histochemistry,
Collegium Medicum, Jagiellonian University,
Medyczna 9, PL 30-688 Krakow, Poland.
Pharmacol Rep. 2005 Nov-Dec;57(6):713-8.
ABSTRACTUnsatisfactory clinical efficacy and a variety of adverse effects of current antidepressant drugs have incited search for better therapy. Zinc, an antagonist of the glutamate/N-methyl-D-aspartate (NMDA) receptor, exhibits antidepressant-like activity in rodent tests/models of depression. Similarly to antidepressants, zinc induces brain derived neurotrophic factor (BDNF) gene expression and increases level of synaptic pool of zinc in the hippocampus. Clinical observations demonstrated serum hypozincemia in depression, which was normalized by effective antidepressant treatment. Moreover, our preliminary clinical study demonstrated the benefit of zinc supplementation in antidepressant therapy. All the data indicate the important role of zinc homeostasis in psychopathology and therapy of depression and potential clinical antidepressant activity of this ion.B6
Calcium and mood
Vitamins and mood
Bad moods and sick hearts
Ascorbic acid, mood, and sex
Natural antidepressants: turmeric (Curcuma longa)
The Good Drug Guide
The Hedonistic Imperative
MDMA/Ecstasy: Utopian Pharmacology
Critique of Aldous Huxley's Brave New World